Liminatus Pharma
LIMN
Liminatus Pharma (LIMN) news
Recent news
Liminatus Pharma, Inc. announces reverse stock split of its common stock
AInvest Wire · Aug 18, 2026Liminatus Pharma - InnocsaI merger valued at $320 mln with $0.2 per share issue price
AInvest Wire · Jun 30, 2026Liminatus Pharma - Innocsa equity holders to receive up to 19.99% of Liminatus common stock
AInvest Wire · Jun 30, 2026Liminatus Pharma amends definitive merger agreement with InnOCSAI to expand oncology cell therapy pipeline
AInvest Wire · Jun 30, 2026Liminatus Pharma enters into warrant exercise transaction for $1.9 million in gross proceeds
AInvest Wire · Jun 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.